The publication aims to look at potential adverse events associated with the use of disease-modifying drugs (DMDs) in people with multiple sclerosis (MS).
Citation
Huah Shin Ng and Feng Zhu and Yinshan Zhao and Shenzhen Yao and Xinya Lu and Okechukwu Ekuma and Charity Evans and John D. Fisk and Ruth Ann Marrie and Helen Tremlett, Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis, Neurology, volume 102, number 3, pages = 208006, year = 2024, doi = 10.1212/WNL.0000000000208006,
https://www.neurology.org/doi/abs/10.1212/WNL.0000000000208006